Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?

    March 2023 in “ Current Oncology ”
    Tongyu C. Wikramanayake, Nicole I. Haberland, Aysun Akhundlu … Mariya Miteva
    Studysummary This study reviews current methods and emerging approaches to prevent and treat chemotherapy-induced hair loss, reporting that evidence-based research is needed to validate effective strategies, which could enhance cancer patients’ quality of life and treatment compliance.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 73

    1. Platelet-Rich Plasma for the Treatment of Alopecia: A Systematic Review and Meta-Analysis PubMed · 2023
    2. Regenerative Medicine Strategies for Hair Growth and Regeneration: A Narrative Review of Literature Regenerative Therapy · 2022
    3. Platelet Rich Plasma and Its Use in Hair Regrowth: A Review Drug design, development and therapy · 2022
    4. Permanent Chemotherapy-Induced Alopecia After Hematopoietic Stem Cell Transplantation Treated With Low-Dose Oral Minoxidil JAAD case reports · 2022
    5. Intralesional Vitamin D3 in Treatment of Alopecia Areata: A Randomized Controlled Clinical Trial Journal of Cosmetic Dermatology · 2022
    6. Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-Analysis JAMA Dermatology · 2022
    7. Spironolactone in Dermatology Dermatologic Therapy · 2022
    8. Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-Induced Cytotoxicity Journal of Cancer · 2022
    9. Applications of the Regenerative Capacity of Platelets in Modern Medicine Cytokine & growth factor reviews · 2021
    10. Cancer-Related Alopecia: From Etiologies to Global Management Cancers · 2021
    11. Alopecia, Chemotherapy, and Scalp Cooling Systems Actas Dermo-Sifiliográficas · 2021
    12. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors JAMA Dermatology · 2021
    13. Role of Vitamin D in Hair Loss: A Short Review Journal of Cosmetic Dermatology · 2021
    14. Peroxisome Proliferator-Activated Receptor-γ Signalling Protects Hair Follicle Stem Cells from Chemotherapy-Induced Apoptosis and Epithelial-Mesenchymal Transition British journal of dermatology/British journal of dermatology, Supplement · 2021
    15. Efficacy and Safety Profile of Oral Spironolactone Use for Androgenic Alopecia: A Systematic Review PubMed · 2021
    16. Treatment of Pediatric Alopecia Areata: A Systematic Review Journal of the American Academy of Dermatology · 2021
    17. Investigating the Safety and Efficacy of Platelet-Rich Plasma Treatment for Female Androgenetic Alopecia: Review of the Literature Medicina-lithuania · 2021
    18. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism Actas Dermo-Sifiliográficas · 2020
    19. Spironolactone in Dermatology: Uses in Acne and Beyond Clinical and Experimental Dermatology · 2020
    20. Oral Minoxidil Treatment for Hair Loss: A Review of Efficacy and Safety Journal of The American Academy of Dermatology · 2020
    21. Prevention and Treatment of Chemotherapy-Induced Alopecia Dermatology practical & conceptual · 2020
    22. Use of Spironolactone in Dermatology: Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism Actas Dermo-Sifiliográficas · 2020
    23. Spironolactone for Treatment of Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2020
    24. The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia Skin appendage disorders · 2019
    25. CDK4/6 Inhibition Mitigates Stem Cell Damage in a Novel Model for Taxane-Induced Alopecia EMBO Molecular Medicine · 2019
    26. Photobiomodulation for the Management of Alopecia: Mechanisms of Action, Patient Selection, and Perspectives Clinical, Cosmetic and Investigational Dermatology · 2019
    27. Impact of a Topical Lotion, CG428, on Permanent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Pilot Randomized Double-Blind Controlled Clinical Trial (VOLUME RCT) Supportive Care in Cancer · 2019
    28. Frontal Fibrosing Alopecia: Efficacy of Treatment Modalities International Journal of Women's Health · 2019
    29. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia JAMA Dermatology · 2019
    30. The Role of Photobiomodulation When Associated with Microneedling in Female Pattern Hair Loss Medicine · 2019
    31. Genetic Analysis of a Novel Antioxidant Multi-Target Iron Chelator, M30, Protecting Against Chemotherapy-Induced Alopecia in Mice BMC cancer · 2019
    32. Off-Label Use of Topical Minoxidil in Alopecia: A Review American Journal of Clinical Dermatology · 2019
    33. Safety of 5α-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies Breast Cancer Research and Treatment · 2018
    34. Complementary and Alternative Treatments for Alopecia: A Comprehensive Review Skin appendage disorders · 2018
    35. Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study ˜The œoncologist · 2018
    36. Chemotherapy-Induced Alopecia: The Urgent Need for Treatment Options JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2018
    37. Female Pattern Hair Loss: A Clinical, Pathophysiologic, and Therapeutic Review International Journal of Women's Dermatology · 2018
    38. Identifying Novel Strategies for Treating Human Hair Loss Disorders: Cyclosporine A Suppresses the Wnt Inhibitor, SFRP1, in the Dermal Papilla of Human Scalp Hair Follicles PLOS Biology · 2018
    39. Hair Disorders in Patients with Cancer Journal of The American Academy of Dermatology · 2018
    40. Intradermal Injections of a Hair Growth Factor Formulation for Enhancement of Human Hair Regrowth: Safety and Efficacy Evaluation in a First-in-Man Pilot Clinical Study Journal of Cosmetic and Laser Therapy · 2018
    41. Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center Facial Plastic Surgery · 2017
    42. Female Pattern Hair Loss: A Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone International Journal of Dermatology · 2017
    43. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification Skin appendage disorders · 2017
    44. A New Path in Defining Light Parameters for Hair Growth: Discovery and Modulation of Photoreceptors in Human Hair Follicle Lasers in surgery and medicine · 2017
    45. Minoxidil Is a Potential Neuroprotective Drug for Paclitaxel-Induced Peripheral Neuropathy Scientific Reports · 2017
    46. Platelet-Rich Plasma for Treatment of Non-Scarring Hair Loss: Systematic Review of Literature Journal of Dermatological Treatment · 2017
    47. Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia Expert Opinion on Investigational Drugs · 2017
    48. Chemotherapy-Induced Alopecia Management: Clinical Experience and Practical Advice Journal of Cosmetic Dermatology · 2017
    49. Multi-Therapies in Androgenetic Alopecia: Review and Clinical Experiences Dermatologic Therapy · 2016
    50. Prevention of Alopecia in Medical and Interventional Chemotherapy Patients Journal of Cutaneous Medicine and Surgery · 2015
    51. Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial British journal of dermatology/British journal of dermatology, Supplement · 2014
    52. The Growth of Human Scalp Hair in Females Using Visible Red Light Laser and LED Sources Lasers in Surgery and Medicine · 2014
    53. Efficacy and Safety of a Low-Level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-Controlled, Double-Blind Study American Journal of Clinical Dermatology · 2014
    54. The Growth of Human Scalp Hair Mediated by Visible Red Light Laser and LED Sources in Males Lasers in Surgery and Medicine · 2013
    55. Low-Level Laser Therapy for Treatment of Hair Loss Lasers in Surgery and Medicine · 2013
    56. Female Pattern Alopecia: Current Perspectives International Journal of Women's Health · 2013
    57. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
    58. Chemoprevention of Doxorubicin-Induced Alopecia in Mice by Dietary Administration of L-Cystine and Vitamin B6 Archives of Dermatological Research · 2012
    59. Low-Level Laser Treatment Accelerated Hair Regrowth in a Rat Model of Chemotherapy-Induced Alopecia Lasers in Medical Science · 2012
    60. A Randomized Double-Blind Placebo-Controlled Pilot Study to Assess the Efficacy of a 24-Week Topical Treatment by Latanoprost 0.1% on Hair Growth and Pigmentation in Healthy Volunteers with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2011
    61. The Alpha-Lipoic Acid Derivative Sodium Zinc Dihydrolipoylhistidinate Reduces Chemotherapy-Induced Alopecia in a Rat Model: A Pilot Study Surgery today · 2011
    62. Bimatoprost in the Treatment of Eyelash Hypotrichosis Clinical ophthalmology · 2010
    63. Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies Seminars in Cutaneous Medicine and Surgery · 2009
    64. Dissecting the Impact of Chemotherapy on the Human Hair Follicle ˜The œAmerican journal of pathology · 2007
    65. Acquired Trichomegaly of the Eyelashes and Hypertrichosis Induced by Bimatoprost Journal of The European Academy of Dermatology and Venereology · 2004
    66. Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia Journal of Investigative Dermatology · 2004
    67. Hypertrichosis of Vellus Hairs in the Malar Region After Unilateral Treatment with Bimatoprost American Journal of Ophthalmology · 2004
    68. Hypertrichosis of Vellus Hairs in the Malar Region After Unilateral Treatment with Bimatoprost American Journal of Ophthalmology · 2004
    69. Tacrolimus in Dermatology Journal of Cutaneous Medicine and Surgery · 2001
    70. Tacrolimus in Dermatology Journal of Cutaneous Medicine and Surgery · 2001
    71. A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia Journal of The American Academy of Dermatology · 1996
    72. Keratinocyte Growth Factor Is an Important Endogenous Mediator of Hair Follicle Growth, Development, and Differentiation. Normalization of the Nu/Nu Follicular Differentiation Defect and Amelioration of Chemotherapy-Induced Alopecia. PubMed · 1995
    73. Minoxidil as a Prophylaxis of Doxorubicin-Induced Alopecia Annals of Oncology · 1994

    Related research 8

    1. Scalp Threading – New Treatment Option for Androgenetic Alopecia South Florida Journal of Health · 2022
    2. Scalp Vascularization as a Marker of Topical Minoxidil Treatment Efficacy in Patients with Androgenetic Alopecia Postepy Dermatologii I Alergologii · 2021
    3. A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan Indian Journal of Dermatology · 2019
    4. Trichoscopy as an Additional Diagnostic Tool for Monitoring of Lichen Planopilaris Aktuelle Dermatologie · 2016
    5. Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium Due to Topical Minoxidil Treatment Skin appendage disorders · 2015
    6. Topical and Intralesional Therapies for Alopecia Areata Dermatologic therapy · 2011
    7. Evaluation of Hair Loss Current problems in dermatology · 1996
    8. Androgenetic Alopecia, Trichotrophic Substances, and Histologic Studies of the Human Scalp Clinics in Dermatology · 1988